Vycor Medical (VYCO) Revenue Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.17% |
| Dec 31, 2025 | 7.41% |
| Sep 30, 2025 | 13.24% |
| Jun 30, 2025 | 15.24% |
| Mar 31, 2025 | 5.73% |
| Dec 31, 2024 | 6.55% |
| Sep 30, 2024 | 3.89% |
| Jun 30, 2024 | -0.27% |
| Mar 31, 2024 | -0.79% |
| Dec 31, 2023 | -6.28% |
| Sep 30, 2023 | -7.52% |
| Jun 30, 2023 | 9.86% |
| Mar 31, 2023 | 2.12% |
| Dec 31, 2022 | 0.11% |
| Sep 30, 2022 | -3.95% |
| Jun 30, 2022 | 1.28% |
| Mar 31, 2022 | -6.03% |
| Dec 31, 2021 | -4.66% |
| Sep 30, 2021 | 0.38% |
| Jun 30, 2021 | 5.31% |
| Mar 31, 2021 | -5.86% |
| Dec 31, 2020 | 0.73% |
| Sep 30, 2020 | 2.59% |
| Jun 30, 2020 | -3.11% |
| Mar 31, 2020 | 0.10% |
| Sep 30, 2019 | -0.69% |
| Jun 30, 2019 | 6.65% |
| Mar 31, 2019 | -0.42% |
| Dec 31, 2018 | 7.20% |
| Sep 30, 2018 | 7.24% |
| Jun 30, 2018 | 5.13% |
| Mar 31, 2018 | 7.01% |
| Dec 31, 2017 | -1.24% |
| Sep 30, 2017 | 11.48% |
| Jun 30, 2017 | 3.00% |
| Mar 31, 2017 | -0.20% |
| Dec 31, 2016 | -5.15% |
| Sep 30, 2016 | 7.09% |
| Jun 30, 2016 | 21.66% |
| Mar 31, 2016 | 22.49% |
| Dec 31, 2015 | 21.51% |
| Sep 30, 2015 | 27.81% |
| Jun 30, 2015 | 30.76% |